G. Auerswald

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

J. Oldenburg, R. Ljung, E. Santagostino, 2017, Thrombosis and Haemostasis.

The EPIC study: a lesson to learn

K. Kurnik, L. Aledort, G. Auerswald, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Treatment of Children with Severe Haemophilia A and Inhibitors: a Health Economic Evaluation for Germany

K. Kurnik, W. Schramm, G. Auerswald, 2013, Klinische Pädiatrie.

Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany

K. Kurnik, W. Schramm, G. Auerswald, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs

V. Jiménez‐Yuste, G. Benson, T. Lambert, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII

G. Auerswald, C. Escuriola-Ettingshausen, G. Auerswald, 1995, Seminars in thrombosis and hemostasis.

Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)

G. Mariani, J. Schved, G. Auerswald, 2000, Blood.